Biotech Values

[midastouch017]

https://www-themarker-com.translate.goog/markets/2024-07-04/ty-article/.premium/00000190-7990-db4b-ab98-7ddee62e0000?_x_tr_sl=iw&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp&_x_tr_hist=true

Mediwound which developed a product for healing wounds, became an attractive target for acquisition

A successful trial of the flagship product that showed superiority over the leading product for healing chronic wounds, fundamental changes in insurance policy in the US and the product's success in treating the burns of the war-wounded in Gaza - all of these made Mediwound an attractive asset for wound healing companies ¦ The American Solventum is interested in acquiring Mediwound at a premium of 118% at its current price

TheMarker is an Israeli financial newspaper:
https://www.themarker.com/markets/2024-07-04/ty-article/.premium/00000190-7990-db4b-ab98-7ddee62e0000